These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 15501074

  • 21. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells.
    Chinery R, Beauchamp RD, Shyr Y, Kirkland SC, Coffey RJ, Morrow JD.
    Cancer Res; 1998 Jun 01; 58(11):2323-7. PubMed ID: 9622066
    [Abstract] [Full Text] [Related]

  • 22. Colorectal cancer and non-steroidal anti-inflammatory drugs.
    Ota S, Bamba H, Kato A.
    Acta Pharmacol Sin; 2000 May 01; 21(5):391-5. PubMed ID: 11324434
    [Abstract] [Full Text] [Related]

  • 23. Role of COX-2 selective inhibitors for prevention and treatment of cancer.
    Amir M, Agarwal HK.
    Pharmazie; 2005 Aug 01; 60(8):563-70. PubMed ID: 16124396
    [Abstract] [Full Text] [Related]

  • 24. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
    Pruthi RS, Derksen E, Gaston K.
    J Urol; 2003 Jun 01; 169(6):2352-9. PubMed ID: 12771797
    [Abstract] [Full Text] [Related]

  • 25. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions.
    Tomisato W, Tsutsumi S, Hoshino T, Hwang HJ, Mio M, Tsuchiya T, Mizushima T.
    Biochem Pharmacol; 2004 Feb 01; 67(3):575-85. PubMed ID: 15037209
    [Abstract] [Full Text] [Related]

  • 26. The prevention of colorectal cancer by aspirin use.
    Giovannucci E.
    Biomed Pharmacother; 1999 Aug 01; 53(7):303-8. PubMed ID: 10472428
    [Abstract] [Full Text] [Related]

  • 27. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 28. Cyclo-oxygenase 2 inhibition in colorectal cancer therapy.
    Church RD, Fleshman JW, McLeod HL.
    Br J Surg; 2003 Sep 15; 90(9):1055-67. PubMed ID: 12945071
    [Abstract] [Full Text] [Related]

  • 29. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.
    Grösch S, Maier TJ, Schiffmann S, Geisslinger G.
    J Natl Cancer Inst; 2006 Jun 07; 98(11):736-47. PubMed ID: 16757698
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
    Tomozawa S, Nagawa H, Tsuno N, Hatano K, Osada T, Kitayama J, Sunami E, Nita ME, Ishihara S, Yano H, Tsuruo T, Shibata Y, Muto T.
    Br J Cancer; 1999 Dec 07; 81(8):1274-9. PubMed ID: 10604722
    [Abstract] [Full Text] [Related]

  • 31. Prospects in NSAID-derived chemoprevention of colorectal cancer.
    Chell S, Patsos HA, Qualtrough D, H-Zadeh AM, Hicks DJ, Kaidi A, Witherden IR, Williams AC, Paraskeva C.
    Biochem Soc Trans; 2005 Aug 07; 33(Pt 4):667-71. PubMed ID: 16042570
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
    Härtel C, von Puttkamer J, Gallner F, Strunk T, Schultz C.
    Scand J Immunol; 2004 Oct 07; 60(4):412-20. PubMed ID: 15379866
    [Abstract] [Full Text] [Related]

  • 35. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
    Pelzmann M, Thurnher D, Gedlicka C, Martinek H, Knerer B.
    J Oral Pathol Med; 2004 Nov 07; 33(10):607-13. PubMed ID: 15482327
    [Abstract] [Full Text] [Related]

  • 36. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.
    Okajima E, Uemura H, Ohnishi S, Tanaka M, Ohta M, Tani M, Fujimoto K, Ozono S, Okajima E, Hirao Y.
    Aktuelle Urol; 2003 Jul 07; 34(4):256-8. PubMed ID: 14566678
    [Abstract] [Full Text] [Related]

  • 37. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
    Saha D, Pyo H, Choy H.
    Am J Clin Oncol; 2003 Aug 07; 26(4):S70-4. PubMed ID: 12902860
    [Abstract] [Full Text] [Related]

  • 38. COX-2 inhibition and prevention of cancer.
    Giercksky KE.
    Best Pract Res Clin Gastroenterol; 2001 Oct 07; 15(5):821-33. PubMed ID: 11566043
    [Abstract] [Full Text] [Related]

  • 39. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
    Reddy BS, Rao CV.
    J Environ Pathol Toxicol Oncol; 2002 Oct 07; 21(2):155-64. PubMed ID: 12086402
    [Abstract] [Full Text] [Related]

  • 40. Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines.
    Buecher B, Bouancheau D, Broquet A, Bezieau S, Denis MG, Bonnet C, Heymann MF, Jarry A, Galmiche JP, Blottière HM.
    Anticancer Res; 2005 Oct 07; 25(1A):225-33. PubMed ID: 15816542
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.